68 related articles for article (PubMed ID: 1297893)
1. The anxiogenic-like effects of pentylenetetrazole in mice treated chronically with carbamazepine or valproate.
de Angelis L
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):767-71. PubMed ID: 1297893
[TBL] [Abstract][Full Text] [Related]
2. The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test.
De Angelis L; Furlan C
Pharmacol Biochem Behav; 2000 Apr; 65(4):649-53. PubMed ID: 10764917
[TBL] [Abstract][Full Text] [Related]
3. Effects of valproate and lorazepam on experimental anxiety: tolerance, withdrawal, and role of clonidine.
de Angelis L
Pharmacol Biochem Behav; 1995 Oct; 52(2):329-33. PubMed ID: 8577798
[TBL] [Abstract][Full Text] [Related]
4. Effects of carbamazepine, valproate calcium, clonazepam and piracetam on behavioral test methods for evaluation of memory-enhancing drugs.
Rostock A; Hoffmann W; Siegemund C; Bartsch R
Methods Find Exp Clin Pharmacol; 1989 Sep; 11(9):547-53. PubMed ID: 2511385
[TBL] [Abstract][Full Text] [Related]
5. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
6. Anxiogenic-like effects of gamma-hydroxybutyric acid (GHB) in mice tested in the light-dark box.
Navarro JF; Dávila G; Pedraza C; Arias JL
Psicothema; 2008 Aug; 20(3):460-4. PubMed ID: 18674444
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological modulation of anxiety-related behaviors in the murine Suok test.
Kalueff AV; Keisala T; Minasyan A; Tuohimaa P
Brain Res Bull; 2007 Sep; 74(1-3):45-50. PubMed ID: 17683788
[TBL] [Abstract][Full Text] [Related]
8. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
[TBL] [Abstract][Full Text] [Related]
9. Picrotoxin blocks the anxiolytic- and panicolytic-like effects of sodium valproate in the rat elevated T-maze.
Dombrowski PA; Fernandes LH; Andreatini R
Eur J Pharmacol; 2006 May; 537(1-3):72-6. PubMed ID: 16626689
[TBL] [Abstract][Full Text] [Related]
10. Role of cyclic GMP in nitrous-oxide-induced anxiolytic-like behavior in the mouse light-dark exploration test.
Li S; Chung E; Quock RM
Behav Neurosci; 2004 Jun; 118(3):648-52. PubMed ID: 15174944
[TBL] [Abstract][Full Text] [Related]
11. [Effect of lithium, carbamazepine, ca-valproate and diazepam on changes in social isolation-induced behavior in mice].
Oehler J; Jähkel M; Schmidt J
Biomed Biochim Acta; 1985; 44(10):1523-30. PubMed ID: 3936492
[TBL] [Abstract][Full Text] [Related]
12. [The effect of isotheoline on mouse behavior under test conditions for detecting its anxiolytic activity].
Zheliazkova-Savova M
Eksp Klin Farmakol; 1998; 61(3):19-21. PubMed ID: 9690069
[TBL] [Abstract][Full Text] [Related]
13. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Mohamed M; Czuczwar SJ
Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
[TBL] [Abstract][Full Text] [Related]
14. Lasting anxiogenic effects of feline predator stress in mice: sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience.
Adamec R; Head D; Blundell J; Burton P; Berton O
Physiol Behav; 2006 Jun; 88(1-2):12-29. PubMed ID: 16624347
[TBL] [Abstract][Full Text] [Related]
15. Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.
Bourin M; Hascoet M; Mansouri B; Colombel MC; Bradwejn J
J Psychiatry Neurosci; 1992 Jun; 17(2):72-7. PubMed ID: 1637802
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice.
Umathe SN; Bhutada PS; Jain NS; Shukla NR; Mundhada YR; Dixit PV
Neuropeptides; 2008 Aug; 42(4):399-410. PubMed ID: 18533256
[TBL] [Abstract][Full Text] [Related]
17. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice.
Tremolizzo L; Doueiri MS; Dong E; Grayson DR; Davis J; Pinna G; Tueting P; Rodriguez-Menendez V; Costa E; Guidotti A
Biol Psychiatry; 2005 Mar; 57(5):500-9. PubMed ID: 15737665
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice.
Hebb AL; Robertson HA; Denovan-Wright EM
Eur Neuropsychopharmacol; 2008 May; 18(5):339-63. PubMed ID: 17913473
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiepileptic drugs carbamazepine and sodium valproate on fertility of male rats.
Soliman GA; Abla Abd ; el-Meguid
Dtsch Tierarztl Wochenschr; 1999 Mar; 106(3):110-3. PubMed ID: 10220947
[TBL] [Abstract][Full Text] [Related]
20. The influence of chronic treatment with psychotropic drugs on behavioral changes by social isolation.
Oehler J; Jähkel M; Schmidt J
Pol J Pharmacol Pharm; 1985; 37(6):841-9. PubMed ID: 3938535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
